Skip to main content

Table 2 Comparison of clinicopathological factors and Cyr61 expression

From: Cyr61 Expression is associated with prognosis in patients with colorectal cancer

Clincopathological factors Cyr61 Total (%) p
Positive N = 157 (%) Negative N = 94 (%)
Age, years, mean (SD) 62.2 (12.2) 65.2 (11.5) 63.3 (12.0) 0.061
Sex     0.296
Male 88 (56.1) 59 (62.8) 147 (58.6)  
Female 69 (43.9) 35 (37.2) 104 (41.4)  
pT stage     0.021
1 8 (5.1) 2 (2.1) 10 (4.0)  
2 20 (12.7) 21 (22.3) 41 (16.3)  
3 105 (66.9) 66 (70.2) 171 (68.1)  
4 24 (15.3) 5 (5.3) 29 (11.6)  
pN stage     0.006
0 73 (46.5) 63 (67.0) 136 (54.2)  
1 56 (35.7) 19 (20.2) 75 (29.9)  
2 28 (17.8) 12 (12.8) 40 (15.9)  
Vascular invasion     0.700
0 136 (86.6) 83 (88.3) 219 (87.3)  
1 21 (13.4) 11 (11.7) 32 (12.7)  
Lymphatic invasion     0.563
0 131 (83.4) 81 (86.2) 212 (84.5)  
1 26 (16.6) 13 (13.8) 39 (15.5)  
TNM stage     0.001
I 17 (10.8) 18 (19.1) 35 (13.9)  
II 51 (32.5) 47 (50.0) 98 (39.0)  
III 79 (50.3) 26 (27.7) 105 (41.8)  
IV 10 (6.4) 3 (3.2) 13 (5.2)